|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008625,
umls-concept:C0009647,
umls-concept:C0017337,
umls-concept:C0021027,
umls-concept:C0023434,
umls-concept:C0032854,
umls-concept:C0033325,
umls-concept:C0040808,
umls-concept:C0332835,
umls-concept:C0392756,
umls-concept:C0439828,
umls-concept:C0522510,
umls-concept:C1515895,
umls-concept:C1561558
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
2005-11-9
|
|
pubmed:abstractText |
To evaluate the efficacy of reduced intensity conditioning (RIC) allogeneic transplant in 30 patients with poor-prognosis chronic lymphocytic leukemia (CLL) and/or high-risk molecular/cytogenetic characteristics.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:CaballeroDoloresD,
pubmed-author:CabreraRafaelR,
pubmed-author:García-MarcoJose AJA,
pubmed-author:GonzálezMarcosM,
pubmed-author:LeónAngelA,
pubmed-author:MartinoRodrigoR,
pubmed-author:MateosVictoriaV,
pubmed-author:RiberaJosé MJM,
pubmed-author:San MiguelJesúsJ,
pubmed-author:SanzGuillermoG,
pubmed-author:SarráJoséJ,
pubmed-author:SierraJorgeJ,
pubmed-author:de la SernaJavierJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
7757-63
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16278397-Adult,
pubmed-meshheading:16278397-Aged,
pubmed-meshheading:16278397-Antigens, CD19,
pubmed-meshheading:16278397-Antigens, CD5,
pubmed-meshheading:16278397-Antigens, CD79,
pubmed-meshheading:16278397-Chromosome Aberrations,
pubmed-meshheading:16278397-Chromosomes, Human, Pair 11,
pubmed-meshheading:16278397-Chromosomes, Human, Pair 17,
pubmed-meshheading:16278397-DNA Mutational Analysis,
pubmed-meshheading:16278397-Disease-Free Survival,
pubmed-meshheading:16278397-Female,
pubmed-meshheading:16278397-Flow Cytometry,
pubmed-meshheading:16278397-Humans,
pubmed-meshheading:16278397-Immunoglobulin Heavy Chains,
pubmed-meshheading:16278397-Kinetics,
pubmed-meshheading:16278397-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:16278397-Male,
pubmed-meshheading:16278397-Middle Aged,
pubmed-meshheading:16278397-Mutation,
pubmed-meshheading:16278397-Prognosis,
pubmed-meshheading:16278397-Proportional Hazards Models,
pubmed-meshheading:16278397-Receptors, IgE,
pubmed-meshheading:16278397-Risk,
pubmed-meshheading:16278397-Stem Cells,
pubmed-meshheading:16278397-Time Factors,
pubmed-meshheading:16278397-Transplantation, Homologous,
pubmed-meshheading:16278397-Transplantation Conditioning,
pubmed-meshheading:16278397-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
|
|
pubmed:affiliation |
Hospital Clínico Universitario de Salamanca, Spain. cabarri@usal.es
|
|
pubmed:publicationType |
Journal Article
|
